RECARBRIO J Code: J0742

Drug & Product Overview

HCPCS Descriptor Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg

HCPCS Added Date July 1, 2020

Manufacturer Merck Sharp & Dohme Corp

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Powder, For Solution

About RECARBRIO

Recarbrio is a medication aligned to the HCPCS J Code: J0742 for billing, pricing, and reimbursement purposes in the United States. It is an Antibiotic drug administered via the intravenous route and manufactured by Merck Sharp & Dohme Corp.

According to CMS Drug Use Information: This medication is used to treat certain serious bacterial infections (such as pneumonia, urinary tract or intra-abdominal infections). This medication is known as a carbapenem-type antibiotic. It works by stopping the growth of bacteria.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00006-3856-02	Recarbrio	Merck Sharp & Dohme LLC	3125	500 MG / 100 ML
•••••-••••-•• Log in to view	RECARBRIO

Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

RECARBRIO Pricing & Reimbursement

J0742 Private Payer Reimbursement

$2.46 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

RECARBRIO CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

CMS does not include Recarbrio (J0742) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0742. Wastage billing guide →

RECARBRIO Medically Unlikely Edits (MUE)

The most billing units of J0742 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 4 mg-4 mg-2 mg.

Practitioner Office & Hospital Outpatient

500 units / day

= 2,000 mg-4 mg-2 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

RECARBRIO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP) Complicated Urinary Tract Infections (cUTI), including Pyelonephritis Complicated Intra-abdominal Infections (cIAI)

Drug Class

Carbapenems [CS]Dipeptidase Inhibitors [MoA]Penem Antibacterial [EPC]Renal Dehydropeptidase Inhibitor [EPC]beta Lactamase Inhibitor [EPC]beta Lactamase Inhibitors [MoA]

Frequently Asked Questions

Is there an available Recarbrio billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for RECARBRIO.

Are there any available Recarbrio patient assistance programs?

RECARBRIO patient assistance information can be found through Merck. Visit Here →

Where can I find Recarbrio prescribing information?

RECARBRIO prescribing information can be found at the link below: Visit Here →

Where can I find Recarbrio side effect information?

Information regarding RECARBRIO's side effects can be found at MedlinePlus Visit Here →

Does billing RECARBRIO require JZ/JW wastage modifiers?

CMS does not include RECARBRIO (J0742) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0742. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.